Supplementary Material from Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations
Authors:
- Zachary S. ZumstegZZZachary S. Zumsteg
- Natasha MorseNMNatasha Morse
- Gabriel KrigsfeldGKGabriel Krigsfeld
- Gaorav GuptaGGGaorav Gupta
- Daniel S. HigginsonDHDaniel S. Higginson
- Nancy Y. LeeNLNancy Y. Lee
- Luc MorrisLMLuc Morris
- Ian GanlyIGIan Ganly
- Stephan L. ShiaoSSStephan L. Shiao
- Simon N. PowellSPSimon N. Powell
- Christine H. ChungCCChristine H. Chung
- Maurizio ScaltritiMSMaurizio Scaltriti
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)